Data● Neutral for Indian equities

Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil

1 source · first seen 17:59 24 Sept · updated 17:59 24 Sept

The brief

Written from 1 report · check the source before you trade

Pharma revenue growth is projected at 11-13% this fiscal
Raw material, energy and freight costs may pressure profitability
Higher input costs may squeeze margins at Indian pharmaceutical companies despite faster revenue growth

Pick a tag to see all its stories

1 report · earliest 17:59